Baker Chad R recently filed their 13F report for the first quarter of 2022, which ended on 2022-03-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
C/O MARSHALL & MELHORN LLC TOLEDO, OH 43604
As of the latest 13F report, the guru’s equity portfolio contained 51 stocks valued at a total of $443,000,000. The top holdings were AAPL(10.84%), TSLA(4.95%), and GOOGL(4.16%).
According to GuruFocus data, these were Baker Chad R’s top five trades of the quarter.
Xilinx Inc
The guru sold out of their 89,530-share investment in NAS:XLNX. Previously, the stock had a 3.93% weight in the equity portfolio. Shares traded for an average price of $197.27 during the quarter.
On 05/11/2022, Xilinx Inc traded for a price of $194.92 per share and a market cap of $48,414,621,000. The stock has returned 40.44% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, Xilinx Inc has a price-earnings ratio of 52.54, a price-book ratio of 13.17, a price-earnings-to-growth (PEG) ratio of 6.33, a EV-to-Ebitda ratio of 37.83 and a price-sales ratio of 13.26.
Advanced Micro Devices Inc
The guru established a new position worth 110,567 shares in NAS:AMD, giving the stock a 2.73% weight in the equity portfolio. Shares traded for an average price of $119.57 during the quarter.
On 05/11/2022, Advanced Micro Devices Inc traded for a price of $88.73 per share and a market cap of $143,787,667,000. The stock has returned 9.58% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, Advanced Micro Devices Inc has a price-earnings ratio of 32.96, a price-book ratio of 2.61, a EV-to-Ebitda ratio of 28.16 and a price-sales ratio of 6.01.
The price-to-GF Value ratio is 0.64, earning the stock a GF Value rank of 8.
Teradyne Inc
The guru established a new position worth 41,465 shares in NAS:TER, giving the stock a 1.11% weight in the equity portfolio. Shares traded for an average price of $127.07 during the quarter.
On 05/11/2022, Teradyne Inc traded for a price of $102.46 per share and a market cap of $16,414,404,000. The stock has returned -21.49% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Teradyne Inc has a price-earnings ratio of 19.02, a price-book ratio of 6.65, a price-earnings-to-growth (PEG) ratio of 0.30, a EV-to-Ebitda ratio of 12.40 and a price-sales ratio of 5.02.
The price-to-GF Value ratio is 0.86, earning the stock a GF Value rank of 9.
SoFi Technologies Inc
The guru established a new position worth 276,600 shares in NAS:SOFI, giving the stock a 0.59% weight in the equity portfolio. Shares traded for an average price of $11.51 during the quarter.
On 05/11/2022, SoFi Technologies Inc traded for a price of $5.25 per share and a market cap of $4,807,457,000. The stock has returned 0.00% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, SoFi Technologies Inc has a price-book ratio of 1.00 and a price-sales ratio of 3.96.
Pacific Biosciences of California Inc
The guru sold out of their 82,875-share investment in NAS:PACB. Previously, the stock had a 0.35% weight in the equity portfolio. Shares traded for an average price of $11.53 during the quarter.
On 05/11/2022, Pacific Biosciences of California Inc traded for a price of $5.33 per share and a market cap of $1,195,964,000. The stock has returned -78.79% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, Pacific Biosciences of California Inc has a price-book ratio of 1.78, a EV-to-Ebitda ratio of -5.32 and a price-sales ratio of 9.22.
The price-to-GF Value ratio is 0.63, earning the stock a GF Value rank of 8.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
